GSK plc GSK on Monday reported interim results from its registrational Phase 2 AZUR-1 trial of Jemperli (dostarlimab) in ...

GSK plc gains attention as oral antibiotic clearance supports its anti-infective position and wider healthcare sector presence.

GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among ...

Shares of GSK PLC GSK slipped 1.69% to £19.21 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.30% to 10,529.39. GSK PLC ...

Sino Biopharmaceutical Limited expanded its strategic partnership with GSK Plc GSK and separately signed an exclusive ...

Clinical setbacks derailed what was once a potentially $2.2 billion deal that marked GSK's return to neuroscience.

Alector faces a strategic reset after GSK’s termination of their neuroscience collaboration, shifting the investment case to ...

GSK (LSE:GSK) has announced positive interim results from the Phase II AZUR-1 trial evaluating Jemperli (dostarlimab) in ...

GSK said Emma Walmsley would step down after more than eight years as chief executive and named its commercial chief, Luke Miels, to succeed her in the top job. Walmsley, who became CEO of the U.K.

Alector has confirmed that an alliance with GSK to develop two drug candidates for dementia has been terminated in the wake ...

GSK said the Nuvalent acquisition aligns with its strategy of snapping up firms with proven science that manufacture better, safer cancer therapies than what’s available on the market.

GSK CH India is the market leader in the health food drinks (HFD) category, with popular brands such as Horlicks and Boost.